Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea · Delayed Price · Currency is KRW 1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 35.56 billion as of October 10, 2025. Its market cap has decreased by -69.37% in one year.
Market Cap
35.56B
Enterprise Value
37.38B
Revenue
820.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,087.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 35.56B, a decrease of -91.81%. That is a compound annual growth rate of -38.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 35.56B | -60.20% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
| Jun 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 579.68T |
| SK hynix | 273.06T |
| LG Energy Solution | 93.37T |
| Samsung Biologics | 71.81T |
| Hanwha Aerospace | 56.44T |
| Hyundai Motor Company | 48.05T |
| HD Hyundai Heavy Industries | 46.87T |
| KB Financial Group | 42.53T |